title: Why therapies for Alzheimer's disease do not work: Do we have consensus over the path to follow?
abstract: Alzheimer's disease (AD) represents a personal tragedy of enormous magnitude, which imposes a daunting worldwide challenge for health-care providers and society as well. In last five decades, global research in clinics and laboratories has illuminated many features of this sinister and eventually fatal disease. Notwithstanding this development, the Alzheimer's research apparently has come across a phase of disappointment and a little reservation about the direction to follow. Persistently distressing controversies and a significant number of missing facts shed further uncertainty about the path forward. A detailed description of some of the main controversies in AD research may assist the field towards finding a resolution. Here I reviewed some alarming concerns or controversies related to these primary issues and emphasized on a possible mechanism to settle them.
authors.affiliation: Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
authors.forename: Zareen
authors.initials: Z
authors.lastname: Amtul
mesh_terms: D000544:Alzheimer Disease / Q000628:therapy*; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D017211:Treatment Failure
keywords: Amyloid; Animal models; Inflammation; Oxidative stress; Tau; Vascuar